(SBRT) experienced significantly fewer toxicities and better quality of life than those who were treated by computed tomography (CT)-guided SBRT according to results of the MRI-Guided Stereotactic Body Radiotherapy for Prostate Cancer (MIRAGE) trial, published in I JAMA Oncology i .[1] The trial...
结论 MRI with targeted and standard biopsy in men with MRI results suggestive of prostate cancer was noninferior to standard biopsy for detecting clinically significant prostate cancer in a population-based screening-by-invitation trial...
"The results also suggest that advanced MRI prior to biopsy could identify about a quarter of men who could safely avoid unnecessary biopsies and in future, could be used to guide prostate biopsy to greatly improve detection of clinically significant cancer." For this strategy to be implemented a...
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and consequent overtreatment as well as underdiagnosis and missed diagnoses in many men. Multiparametric MRI (mpMRI) of the prostate has been identified as a test that could mitigate these diagnostic errors. The performanc...
The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) with targeted biopsies (MRI-TBx) matches the current standard and brings a multitude
[15] Wetter A, Nensa F, Lipponer C, et al.High and ultra-high b-value diffusion-weighted imaging in prostate cancer: aquantita-tive analysis. Acta Radiol, 2015, 56(8): 1009-1015. [16] Wang X, Qian Y, Liu B, et al.High-b-value diffusion-weighted MRI for the detection of prost...
Urology 66 (Suppl 5A): S47–S51 Experience counts: MRI-based prostate-cancer staging Controversy rages over which imaging tech- nique to use in the localization and staging of prostate cancer. Many small studies have been done, with contradictory results, but the differences in the imaging ...
(2013) Prostate Cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor. AJR 3:W471–W478CrossRef 41. Turkbey B, Pinto PA, Mani H, et al. (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection—histopathologic ...
TULSA Effective in Controlling Prostate Cancer Long-Term— At 5 years, median PSA was reduced by 90%。 WASHINGTON -- Results from a long-term follow-up of the pivotal TACT trial showed that MRI-guided transurethral ul...
[22] Overduin CG, Fütterer JJ, Barentsz JO. MRI-guided biopsy for prostate cancer detection: a systematic review of current clinical results. Curr Urol Rep 2013;14:209-13. [23] Bains LJ, Studer UE, Froehlich JM, et al. Diffusion-weighted magnetic resonance imaging detects significant prosta...